Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Menssen · SciRah

Researcher profile · Semantic Scholar

H. Menssen

Share profile

H. Menssen — researcher profile on SciRah

h-index: 32
Works: 70
Citations: 5,547

Most-cited papers

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
A. Hochhaus, R. Larson, F. Guilhot, J. Radich +11 more
2017New England Journal of Medicine1,089 citations Open access
Semantic Scholar
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
A. Hochhaus, G. Saglio, T. Hughes, R. Larson +13 more
2016Leukemia753 citations Open access
Semantic Scholar
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
P. Major, A. Lortholary, J. Hon, E. Abdi +7 more
2001Journal of Clinical Oncology749 citations
Semantic Scholar
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
H. Menssen, H. Renkl, U. Rodeck, J. Maurer +4 more
1995Leukemia289 citations
Semantic Scholar
Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.
T. Hughes, G. Saglio, H. Kantarjian, F. Guilhot +10 more
2014Blood259 citations Open access
Semantic Scholar
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.
M. Johannsen, G. Spitaleri, G. Curigliano, J. Roigas +17 more
2010European Journal of Cancer182 citations
Semantic Scholar
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.
S. Sauer, P. Erba, M. Petrini, A. Menrad +9 more
2009Blood168 citations
Semantic Scholar
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.
C. Schliemann, A. Palumbo, Kathrin Zuberbühler, A. Villa +5 more
2009Blood161 citations Open access
Semantic Scholar
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
H. Menssen, A. Sakalová, A. Fontana, Z. Herrmann +10 more
2002Journal of Clinical Oncology158 citations
Semantic Scholar
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
T. Eigentler, B. Weide, F. D. de Braud, G. Spitaleri +12 more
2011Clinical Cancer Research147 citations
Semantic Scholar
ED-B fibronectin as a target for antibody-based cancer treatments
A. Menrad, H. Menssen
2005Expert opinion on therapeutic targets104 citations
Semantic Scholar
Wilms' tumour gene 1 (WT1) in human neoplasia
Ulrich Keilholz, H. Menssen, A. Gaiger, A. Menke +6 more
2005Leukemia99 citations Open access
Semantic Scholar
Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours
G. Spitaleri, R. Berardi, Chiara Pierantoni, T. De Pas +8 more
2013Journal of Cancer Research and Clinical Oncology96 citations Open access
Semantic Scholar
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina.
Jian-Xiang Wang, Zhi-xiang Shen, G. Saglio, Jie Jin +16 more
2015Blood94 citations Open access
Semantic Scholar
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
T. Dietrich, T. Hucko, C. Schneemann, M. Neumann +7 more
2012Atherosclerosis80 citations
Semantic Scholar
Wilms' tumor gene expression in human CD34+ hematopoietic progenitors during fetal development and early clonogenic growth.
H. Menssen, H. Renkl, M. Entezami, E. Thiel
1997Blood76 citations
Semantic Scholar
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
P. Erba, M. Sollini, E. Orciuolo, C. Traino +8 more
2012Journal of Nuclear Medicine72 citations Open access
Semantic Scholar
Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens
H. Menssen, E. Bertelmann, S. Bartelt, R. Schmidt +3 more
2000Journal of Cancer Research and Clinical Oncology67 citations Open access
Semantic Scholar
Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia
H. Menssen, H. Renkl, U. Rodeck, Chaba Kari +2 more
1997International Journal of Cancer65 citations
Semantic Scholar
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer
C. Catania, M. Maur, R. Berardi, A. Rocca +15 more
2015Cell Adhesion & Migration58 citations Open access
Semantic Scholar
ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes
G. Saglio, A. Hochhaus, T. Hughes, R. Clark +13 more
201353 citations
Semantic Scholar
Efficacy and Safety of Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Long-Term Follow-Up (f/u) of ENESTnd
R. Larson, Dong-Wook Kim, Surapol Issaragrilsil, P. le Coutre +12 more
201451 citations
Semantic Scholar
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
M. Pless, K. Belhadj, H. Menssen, W. Kern +10 more
2004Clinical Cancer Research51 citations Open access
Semantic Scholar
Targeting MDM2 enhances anti-leukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.
Jenny N. H. G. Ho, Dominik Schmidt, T. Lowinus, Jeongmin Ryoo +39 more
2022Blood48 citations Open access
Semantic Scholar
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
K. Hartmann, J. Gotlib, C. Akin, O. Hermine +12 more
2020Journal of Allergy and Clinical Immunology47 citations Open access
Semantic Scholar
Expression of Wilms’ tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants
J. Siehl, M. Reinwald, K. Heufelder, H. Menssen +2 more
2004Annals of Hematology44 citations
Semantic Scholar
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
T. Hughes, A. Hochhaus, H. Kantarjian, F. Cervantes +12 more
2014Haematologica43 citations Open access
Semantic Scholar
Cryptococcosis in Hodgkin's disease: description of two cases and review of the literature
A. Korfel, H. Menssen, Stefan Schwartz, E. Thiel
1998Annals of Hematology43 citations
Semantic Scholar
Wilms Tumor Gene (WT1) Expression as a Panleukemic Marker
H. Menssen, J. Siehl, E. Thiel
2002International journal of hematology34 citations
Semantic Scholar
Tumor progression in the human melanocytic system.
R. Kath, U. Rodeck, H. Menssen, M. Mancianti +3 more
1989Anticancer Research34 citations
Semantic Scholar
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
L. Aloj, L. D'Ambrosio, M. Aurilio, Anna Morisco +9 more
2014European Journal of Nuclear Medicine and Molecular Imaging33 citations
Semantic Scholar
ENESTnd 5-year (y) update: Long-term outcomes of patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib (NIL) versus imatinib (IM).
R. Larson, Dong-Wook Kim, S. Jootar, R. Pasquini +11 more
201432 citations
Semantic Scholar
Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient
R. Locher, P. Erba, B. Hirsch, E. Bombardieri +4 more
2013Journal of Cancer Research and Clinical Oncology26 citations Open access
Semantic Scholar
CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up‐regulated in distinct human leukaemias
A. Burchert, M. Notter, H. Menssen, S. Schwartz +3 more
1999British Journal of Haematology26 citations Open access
Semantic Scholar
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production
Marlene Langenbach, S. Giesler, Stefan Richtsfeld, Sara da Costa-Pereira +18 more
2023Molecular Cancer Research24 citations Open access
Semantic Scholar
The Use of Hirudin as Universal Anticoagulant in Haematology, Clinical Chemistry and Blood Grouping
H. Menssen, K. Melber, Natascha Brandt, E. Thiel
2001Clinical Chemistry and Laboratory Medicine23 citations
Semantic Scholar
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model
H. Menssen, U. Harnack, U. Erben, D. Neri +2 more
2018Journal of Cancer Research and Clinical Oncology22 citations Open access
Semantic Scholar
Treatment-free remission (TFR) following nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath.
F. Mahon, M. Baccarani, M. Mauro, T. Hughes +7 more
201421 citations
Semantic Scholar
Impact of Treatment with Frontline Nilotinib (NIL) vs Imatinib (IM) on Sustained Deep Molecular Response (MR) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
A. Hochhaus, G. Saglio, T. Hughes, R. Larson +4 more
201519 citations
Semantic Scholar
Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies.
M. Czabanka, G. Parmaksiz, S. Bayerl, M. Nieminen +5 more
2011European Journal of Cancer18 citations
Semantic Scholar
Combination of the immunocytokine F16-IL2 with doxorubicin or paclitaxel in patients with solid tumors: Results from two phase Ib trials.
F. D. de Braud, C. Catania, A. Onofri, Chiara Pierantoni +9 more
2011Journal of Clinical Oncology17 citations
Semantic Scholar
A dose finding pharmacokinetic study of the tumor-targeting human L19-IL2 monoclonal antibody-cytokine fusion protein in patients with advanced solid tumors
G. Curigliano, G. Spitaleri, T. De Pas, C. Noberasco +6 more
200713 citations
Semantic Scholar
Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubes.
H. Menssen, Natascha Brandt, Rainer Leben, Frank Müller +2 more
2001Seminars in Thrombosis and Hemostasis11 citations
Semantic Scholar
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib: Results from the ENESTFreedom study.
A. Hochhaus, T. Masszi, F. Giles, J. Radich +16 more
201610 citations
Semantic Scholar
Analysis of Wilms Tumor Gene (WT1) Expression in Acute Leukemia Patients with Special Reference to the Differential Diagnosis between Eosinophilic Leukemia and Idiopathic Hypereosinophilic Syndromes
H. Menssen, A. Schmidt, S. Bartelt, A. Arjomand +4 more
2000Leukemia and Lymphoma9 citations
Semantic Scholar
Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myeloma.
H. Szelényi, E. Kreuser, Ulrich Keilholz, H. Menssen +4 more
2001Annals of Oncology6 citations Open access
Semantic Scholar
A quantitative electron microscopic study of the effect of glucocorticoids in vivo on the early postnatal differentiation of paraneuronal cells in the carotid body and the adrenal medulla of the rat
G. K. V. Dalnok, H. Menssen
2004Anatomy and Embryology5 citations
Semantic Scholar
Haemophagocytosis in bone marrow rhabdomyosarcoma
S. Schwartz, H. Menssen, E. Thiel
1999British Journal of Haematology4 citations
Semantic Scholar
Frontline Nilotinib Results In Superior Rates Of Molecular Response Versus Imatinib In Chinese Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTchina 12-Month Primary Analysis
Jian-Xiang Wang, M. Baccarani, S. Jevtic, C. Ortmann +4 more
20133 citations
Semantic Scholar
Radioimmunotherapy (RIT) with 131l-L19SIP in solid cancers (SC) and lymphoproliferative diseases: Final results of the first human trial.
G. Del Conte, P. Erba, A. Fasolo, Carlo Chiesa +6 more
20103 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Neri×13
Invite
D. Neri — researcher profile on SciRah
G. Saglio×11
Invite
G. Saglio — researcher profile on SciRah
L. Giovannoni×10
Invite
L. Giovannoni — researcher profile on SciRah
A. Hochhaus×9
Invite
A. Hochhaus — researcher profile on SciRah

×9

Invite

T. Hughes — researcher profile on SciRah

Invite

E. Thiel — researcher profile on SciRah

Invite

R. Larson — researcher profile on SciRah

H. Kantarjian×8

Invite

H. Kantarjian — researcher profile on SciRah

Invite

E. Thiel — researcher profile on SciRah

F. D. de Braud×6

Invite

F. D. de Braud — researcher profile on SciRah

Invite

W. Deng — researcher profile on SciRah

G. Spitaleri×5

Invite

G. Spitaleri — researcher profile on SciRah